Skip to content

Observation of clinical effect of Fu’s subcutaneous needling(FSN) combined with reperfusion therapy on patients with nonspecific low back pain

Observation of clinical effect of Fu’s subcutaneous needling(FSN) combined with reperfusion therapy on patients with nonspecific low back pain

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300073325
Enrollment
Unknown
Registered
2023-07-06
Start date
2023-07-07
Completion date
Unknown
Last updated
2023-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

nonspecific low back pain

Interventions

Fu’s subcutaneous needling(FSN) group:Fu’s subcutaneous needling therapy
sham FSN group (sham FSN+ voltaren external use):sham FSN+ voltaren external use
voltaren external use :voltaren external use

Sponsors

The First Affiliated Hospital of Guangzhou University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: ?Patients with chronic non-specific low back pain. (Refer to the 2020 North American Spine Association (NASS) Evidence-Based Medicine guidelines for nonspecific low back pain: Patients 18 years of age and older; Pain comes from referred or non-root pain.) ?Age ranges from 18 to 60 years old and gender is not limited. ? The course of the disease lasted more than 12 weeks, and the VAS score was =4 points. ? Supporting this study and signing informed consent, assisting physicians to complete the whole study process. ? No other treatment was used for lumbago.

Exclusion criteria

Exclusion criteria: ? pregnancy; ? Specific low back pain (tumor, infection, metabolic disease, rheumatoid arthritis, fracture); ? Spinal deformity (spondylolishesis , spondylolysis or scoliosis); ? Pain below the knee; ? Extra-spinal diseases (such as vascular and genitourinary diseases); ? History of lumbar surgery; ? "lumbar disc herniation", "lumbar spinal stenosis" and other root pain; ?Lumbago with =2 other areas of pain ? Patients who received acupuncture treatment in the past 1 month of the experiment.

Design outcomes

Primary

MeasureTime frame
Visual analog pain scale (VAS);

Secondary

MeasureTime frame
Muscle cross-sectional area (CSA) ;

Countries

China

Contacts

Public ContactLiang Zheng

The First Affiliated Hospital of Guangzhou University of Chinese Medicine

zhliang66@aliyun.com+86 138 0253 3166

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026